Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain (Q33879577)

29 July 2017

title

Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain (English)

1 reference

29 July 2017

Nicolas Ardes-Guisot

1

1 reference

29 July 2017

Dominic S Alonzi

2

1 reference

29 July 2017

Gabriele Reinkensmeier

3

1 reference

29 July 2017

Terry D Butters

4

1 reference

29 July 2017

Caroline Norez

5

1 reference

29 July 2017

Frédéric Becq

6

1 reference

29 July 2017

Yousuke Shimada

7

1 reference

29 July 2017

Shinpei Nakagawa

8

1 reference

29 July 2017

Atsushi Kato

9

1 reference

29 July 2017

Yves Blériot

10

1 reference

29 July 2017

Matthieu Sollogoub

11

1 reference

29 July 2017

Boris Vauzeilles

12

1 reference

29 July 2017

publication date

21 April 2011

1 reference

Organic and Biomolecular Chemistry

29 July 2017

published in

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

issue

15

1 reference

29 July 2017

page(s)

5373-5388

1 reference

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Functionalized pyrrolidines inhibit alpha-mannosidase activity and growth of human glioblastoma and melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Antiviral effects of an iminosugar derivative on flavivirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Iminosugars and relatives as antiviral and potential anti-infective agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Glycosidase inhibitors as potential HIV entry inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Glycosylation inhibitors in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

A cystic fibrosis respiratory epithelial cell chronically treated by miglustat acquires a non-cystic fibrosis-like phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

X-ray structure of human acid-β-glucosidase, the defective enzyme in Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic fibrosis transmembrane conductance regulator chloride channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Quality control in the endoplasmic reticulum protein factory

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Glycosidase inhibition with fullerene iminosugar balls: a dramatic multivalent effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Multivalent iminosugars to modulate affinity and selectivity for glycosidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Fluorescently tagged iminoalditol glycosidase inhibitors as novel biological probes and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Synthesis and biological characterisation of novel N-alkyl-deoxynojirimycin alpha-glucosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Phenylenediamine catalysis of "click glycosylations" in water: practical and direct access to unprotected neoglycoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Targeting glycosylation as a therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Glycosphingolipids--nature, function, and pharmacological modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

4-C-Me-DAB and 4-C-Me-LAB - enantiomeric alkyl-branched pyrrolidine iminosugars - are specific and potent α-glucosidase inhibitors; acetone as the sole protecting group

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Rapid chromatographic technique for preparative separations with moderate resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and choline transport systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

A cystic fibrosis tracheal gland cell line, CF-KM4. Correction by adenovirus-mediated CFTR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Development of a single column method for the separation of lipid- and protein-derived oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

New synthetic seven-membered 1-azasugars displaying potent inhibition towards glycosidases and glucosylceramide transferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB05119A

21 January 2018

Identifiers

DOI

10.1039/C1OB05119A

1 reference

29 July 2017

1 reference